The relationship between health, disability and quality of life in Myasthenia Gravis: Results from an Italian study

Journal of Neurology

Volumn 257, Issue 1, 2010, Pages 98-102

  Leonardi, Matilde ^a   Raggi, Alberto ^a   Antozzi, Carlo ^a   Confalonieri, Paolo ^a   Maggi, Lorenzo ^a   Cornelio, Ferdinando ^a   Mantegazza, Renato ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Disability; Health related quality of life; Myasthenia Gravis; SF 36; WHO DAS II

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE; MYASTHENIA GRAVIS; PHYSICAL DISABILITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANK SUM TEST; SCORING SYSTEM; SHORT FORM 36; SOCIAL PSYCHOLOGY;

DISABILITY EVALUATION; FEMALE; HEALTH STATUS; HUMANS; ITALY; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 74849127919     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5279-z     Document Type: Article

References (22)

1. G Apolone P Mosconi 1998 The Italian SF-36 health survey: translation, validation and norming J Clin Epidemiol 51 1025 1036 10.1016/S0895-4356(98) 00094-8 1:STN:280:DyaK1M%2Fjt1Sisg%3D%3D 9817120 (Pubitemid 28527158)
2. TM Burns MR Conaway GR Cutter DB Sanders Muscle Study Group 2008 Less is more, or almost as much: a 15-item quality of life instrument for myasthenia gravis Muscle Nerve 38 957 963 10.1002/mus.21053 18642357
3. MA Buist-Bouwman R De Graaf WA Vollebergh J Alonso R Bruffaerts J Ormel 2006 Functional disability of mental disorders and comparison with physical disorders: a study among the general population of six European countries Acta Psychiatr Scand 113 492 500 10.1111/j.1600-0447.2005.00684.x 1:STN:280:DC%2BD283lt1ekug%3D%3D 16677226 (Pubitemid 43748605)
4. TH Chisolm HB Abrams R McArdle RH Wilson PJ Doyle 2005 The WHO-DAS II: psychometric properties in the measurement of functional health status in adults with acquired hearing loss Trends Amplif 9 111 126 10.1177/108471380500900303 16244758 (Pubitemid 41566993)
5. PK Chopra JW Couper H Herrman 2004 The assessment of patients with long-term psychotic disorders: application of the WHO Disability Assessment Schedule II Aust NZ J Psychiatry 38 753 759 1:STN:280:DC%2BD2cvhvVCntA%3D%3D
6. LA Chwastiak M Von Korff 2003 Disability in depression and back pain: evaluation of the World Health Organization Disability Assessment Schedule (WHO-DAS II) in a primary care setting J Clin Epidemiol 54 507 514 10.1016/S0895-4356(03)00051-9 (Pubitemid 36842907)
7. BM Conti-Fine M Milani HJ Kaminski 2006 Myasthenia gravis: past, present, and future J Clin Invest 116 2843 2854 10.1172/JCI29894 1:CAS:528: DC%2BD28XhtFyrsLnE 17080188 (Pubitemid 44684466)
8. R D'Alessandro M Casmiro G Benassi R Rinaldi G Gamberoni 1995 Reliable disability scale for myasthenia gravis sensitive to clinical changes Acta Neurol Scand 92 77 82 7572067
9. A Garratt L Schmidt A Mackintosh R Fitzpatrick 2002 Quality of life measurement: bibliographic study of patient assessed health outcome measures BMJ 324 1417 10.1136/bmj.324.7351.1417 12065262
10. C Guy-Coichard DT Nguyen T Delorme F Boureau 2008 Pain in hereditary neuromuscular disorders and myasthenia gravis: a national survey of frequency, characteristics and impact J Pain Symptom Manage 35 40 50 10.1016/j.jpainsymman. 2007.02.041 17981001 (Pubitemid 350299096)
11. A Jaretzki 3rd RJ Barohn RM Ernstoff HJ Kaminski JC Keesey AS Penn DB Sanders 2000 Myasthenia gravis: recommendations for clinical research standards: Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America Neurology 55 16 23 10891897
12. D Lavrnic A Vujic V Rakocevic-Stojanovic Z Stevic I Basta S Pavlovic R Trikic S Apostolski 2005 Cyclosporine in the treatment of myasthenia gravis Acta Neurol Scand 111 247 252 10.1111/j.1600-0404.2005.00378.x 1:CAS:528: DC%2BD2MXjtVymu7s%3D 15740576 (Pubitemid 40380460)
13. M Leonardi J Bickenbach TB Ustun N Kostanjsek S Chatterji MHADIE consortium 2006 The definition of disability: what is in a name? Lancet 368 1219 1221 10.1016/S0140-6736(06)69498-1 17027711 (Pubitemid 44485780)
14. R Mantegazza C Antozzi D Peluchetti A Sghirlanzoni F Cornelio 1988 Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis J Neurol 235 449 453 10.1007/BF00314245 1:STN:280:DyaL1M%2FpsVChtQ%3D%3D 3062134 (Pubitemid 18262976)
15. R Mantegazza F Baggi C Antozzi, et al. 2003 Myasthenia gravis (MG): epidemiological data and prognostic factors Ann NY Acad Sci 998 413 423 10.1196/annals.1254.054 14592909 (Pubitemid 37194193)
16. LL Mullins MY Carpentier RH Paul DB Sanders the Muscle Study Group 2008 Disease-specific measure of quality of life for Myasthenia Gravis Muscle Nerve 38 947 956 10.1002/mus.21016 18697209
17. L Padua A Evoli I Aprile P Caliandro S Mazza R Padua P Tonali 2001 Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements Neurol Sci 22 363 369 10.1007/s100720100066 1:STN:280:DC%2BD387os1aksw%3D%3D 11917973
18. RH Paul JM Nash RA Cohen JM Gilchristh JM Goldstein 2001 Quality of life and well-being of patients with Myasthenia Gravis Muscle Nerve 24 512 516 10.1002/mus.1034 1:STN:280:DC%2BD3M7ntVSrsQ%3D%3D 11268023 (Pubitemid 32246787)
19. A Rostedt L Padua EV Stalberg 2006 Correlation between regional myasthenic weakness and mental aspects of quality of life Eur J Neurol 13 191 193 10.1111/j.1468-1331.2006.01149.x 1:STN:280:DC%2BD287gtlemug%3D%3D 16490052
20. Ustun TB (1999) WHO-DAS II field trials report 1998. WHO, Geneva
21. A Vincent J Palace D Hilton-Jones 2001 Myasthenia Gravis Lancet 357 2122 2128 10.1016/S0140-6736(00)05186-2 1:STN:280:DC%2BD3MzptVOjtQ%3D%3D 11445126 (Pubitemid 32607461)
22. World Health Organization (2001) The International Classification of Functioning, Disability and Health-ICF. WHO, Geneva